Zobrazeno 1 - 10
of 103
pro vyhledávání: '"E Bolling"'
Autor:
K Lauritsen, K Rutgersson, E Bolling, G Brunner, S Eriksson, JP Galmiche, A Walan, AP Archambault, H Gudjónsson, RJ Bailey, G Bianchi Porro, L Frison, N Havu, ABR Thompson
Publikováno v:
Canadian Journal of Gastroenterology, Vol 13, Iss 10, Pp 806-813 (1999)
BACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to beco
Externí odkaz:
https://doaj.org/article/165a5db58c974870966171236b77b51b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bernhard Meirose, Viktor Abelin, Fredrik Bertilsson, Benjamin E. Bolling, Mathias Brandin, Michael Holz, Rasmus Høier, Andreas Johansson, Sebastian Kalbfleisch, Per Lilja, Johan S. Lundquist, Stephen Molloy, Filip Persson, Jonas E. Petersson, Hugo Serodio, Robin Svärd, David Winchester
Publikováno v:
Instruments, Vol 4, Iss 3, p 26 (2020)
In this paper, beam diagnostic and monitoring tools developed by the MAX IV Operations Group are discussed. In particular, beam position monitoring and accelerator tunes visualization software tools, as well as tools that directly influence the beam
Externí odkaz:
https://doaj.org/article/89d97c2dd5f34b1490084f411506ad7b
Autor:
Filip Persson, Bernhard Meirose, Sebastian Kalbfleisch, Hugo Serodio, David Winchester, Michael Holz, Fredrik Bertilsson, Per Lilja, Benjamin E. Bolling, Mathias Brandin, Rasmus Høier, Andreas Johansson, Johan S. Lundquist, Stephen Molloy, Jonas E. Petersson, Robin Svärd, Viktor Abelin
Publikováno v:
Instruments, Vol 4, Iss 26, p 26 (2020)
Instruments
Volume 4
Issue 3
Instruments
Volume 4
Issue 3
In this paper, beam diagnostic and monitoring tools developed by the MAX IV Operations Group are discussed. In particular, beam position monitoring and accelerator tunes visualization software tools, as well as tools that directly influence the beam
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Franceschi, G. Bianchi Porro, L. Capurso, E. Bolling, Luigi Barbara, M. Lazzaroni, A. Mangiameli, Roberto Corinaldesi, Paolo Paoluzi, F. Sabbatini
Publikováno v:
Alimentary Pharmacology & Therapeutics. 8:541-548
SUMMARY Background: The aim of this study was to compare omeprazole 10 mg o.m. (daily) with omeprazole 20 mg o.m. on Friday to Sunday inclusive (weekend) in the prevention of duodenal ulcer relapse over a 6-month period. Methods: After an open healin
Autor:
Manfred Stolte, Jukka Ronkainen, Nicholas J. Talley, Lars Agréus, Pertti Aro, Hans Graffner, Michael Vieth, E. Bolling-Sternevald, Sven-Erik Johansson, Tore Lind, Lars Engstrand, Tom Storskrubb
Publikováno v:
Scandinavian Journal of Gastroenterology. 40:275-285
Objective. Gastroesophageal reflux disease has been reported to be a common burden on health-care resources in the Western world, but its manifestations in the general population are as yet unclear. The aim of this study was to estimate the prevalenc
Autor:
Pertti Aro, Nicholas J. Talley, Michael Vieth, E. Bolling-Sternevald, Karin Wreiber, Lars Agréus, Lars Engstrand, Henry Nyhlin, Tom Storskrubb, Jukka Ronkainen, Manfred Stolte
Publikováno v:
Scandinavian Journal of Gastroenterology. 40:302-311
Objective. Corpus-dominant gastritis, gastric mucosal atrophy and intestinal metaplasia (IM) associated with Helicobacter pylori infection are all known potential risk markers for the development of gastric cancer. As the accuracy for finding cases a
Autor:
Manfred Stolte, A. L. Blum, Hazel M. Mitchell, E. Bolling-Sternevald, Colm O'Morain, Nicholas J. Talley, Hua-Xiang Xia
Publikováno v:
Alimentary Pharmacology & Therapeutics. 17:935-943
Aim: To determine whether pre-treatment antibody response to Helicobacter pylori virulence factors predicts eradication success and symptom relief 12 months after triple therapy in non-ulcer dyspep ...